Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for February 2017

MicroPharm Secures Biomedical Catalyst 2016 Grant

MicroPharm Limited announced that it has secured a grant of £195,567 to further support the development of OraCAb, a therapeutic for oral administration of polyclonal antibodies to treat Clostridium difficile infections.

Read the full story

Posted on: Wednesday, 1st February 2017